Amedisys, nVoq present outcomes from speech recognition study

nVoq Incorporated collaborated with Amedisys to present outcomes realized during a 2022 joint study of speech recognition impact on documentation quality at the PALTC23 conference in Tampa, Florida. Amedisys leveraged nVoq’s Speech Recognition Solution to improve the quality, consistency, and timeliness of clinical narrative notes. Throughout 2022, Amedisys conducted a Quality Improvement study to assess the effectiveness of speech recognition in documenting the Certification of Terminal Illness. The results were measured across content quality, physician experience, and meeting documentation requirements. The key improvements that are featured in the study focused on the quality of the hospice patient narrative when using speech recognition versus manually typing the narrative which included a 39% increase of the use of prognostic statements, a 35% improvement of statements describing disease progression, and 10% increase in reporting the palliative performance scale.